SCHEMBL12283532

SCHEMBL12283532

CC(C)(C)OC(=O)N[C@@H]1CCCN(c2c(Cl)cccc2C=O)C1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.49
▸ JAK3 P52333 1/20 0.49
▸ MAP4K4 O95819 2/20 0.49
▸ DRD2 P14416 3/20 0.48
▸ PIM1 P11309 1/20 0.47
▸ PIM3 Q86V86 1/20 0.47
▸ PIM2 Q9P1W9 1/20 0.47
▸ DRD3 P35462 1/20 0.46
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ PDE10A Q9Y233 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ AURKA O14965 3/20 0.41
▸ PDPK1 O15530 3/20 0.41
▸ AURKB Q96GD4 3/20 0.41
▸ KDM4D Q6B0I6 1/20 0.41
▸ KIF18A Q8NI77 1/20 0.40
▸ CTSK P43235 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12283853 0.94 PIM1 (0.52) BTKJAK3DRD2PIM1PIM3
SCHEMBL12283734 0.94 PIM1 (0.52) BTKJAK3DRD2PIM1PIM3
SCHEMBL2425209 0.88 MAP4K4 (0.49) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL12283721 0.88 MAP4K4 (0.49) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL12284173 0.87 MAP4K4 (0.48) BTKJAK3MAP4K4PIM1PIM3
SCHEMBL2423232 0.85 MAP4K4 (0.47) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL2423233 0.85 MAP4K4 (0.47) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL12322730 0.85 MAP4K4 (0.47) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL12323317 0.85 MAP4K4 (0.46) BTKJAK3MAP4K4DRD2PIM1
SCHEMBL12283559 0.85 MAP4K4 (0.48) BTKJAK3MAP4K4DRD2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 BTK 20/4885JAK3 40/4885MAP4K4 176/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 BTK 27/4885JAK3 62/4885MAP4K4 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback